Elicio Therapeutics (ELTX) Short-term Investments (2022 - 2025)

Elicio Therapeutics has reported Short-term Investments for 4 years, with the latest figure at $683000.0 in Q1 2025.

• For the quarter ending Q1 2025, Short-term Investments fell 2.43% year-over-year to $683000.0; the trailing twelve-month figure through Mar 2025 stood at $683000.0 (down 2.43% YoY), and the FY2024 full-year result was $1.2 million, up 63.16% from the prior year.
• Short-term Investments for Q1 2025 stood at $683000.0, down from $1.2 million in the prior quarter.
• The five-year high for Short-term Investments was $1.7 million in Q3 2023, with the low at $396000.0 in Q2 2024.
• Historically, Short-term Investments has averaged $1.0 million across 4 years, with a median of $950000.0 in 2023.
• Annual changes were most pronounced in 2023 — Short-term Investments slumped 56.0% — and 2024, when it soared 63.16%.
• Elicio Therapeutics' Short-term Investments stood at $1.6 million in 2022, then tumbled by 56.0% to $722000.0 in 2023, then soared by 63.16% to $1.2 million in 2024, then slumped by 42.02% to $683000.0 in 2025.
• The last three Short-term Investments figures came in at $683000.0 (Q1 2025), $1.2 million (Q4 2024), and $1.3 million (Q3 2024), per Business Quant data.